glp-1 users need strength training to prevent muscle loss How on Medications (Complete Guide) Ozempic, GLP-1s, and Muscle Loss:

Accessed 20 Jun 2022 Frias JP, Bonora E, Nevarez Ruiz L et al (2021) Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)

9 During traditional weight loss methods like dieting alone, it's estimated that lean body mass can account for roughly 20-35% of the total weight lost

For this reason, having a thorough understanding of what matters most to people living with AD/ADRD can inform the development of interventions that better address their quality of life and well-being (Jessen et al., 2022)

Such changes may also impact insulin sensitivity, organ function, and systemic inflammation, suggesting a new microbiota-mediated axis in the treatment of T2DM

Healthy eating combined with weight loss medication and an active lifestyle will benefit patients as they begin to lose weight

CrossRef Pharmacological Strategies for Insulin Sensitivity in Obesity and Cancer: Thiazolidinediones and Metformin Luana A